famvir 500 mg tabletti, kalvopäällysteinen
phoenix labs - famciclovir - tabletti, kalvopäällysteinen - 500 mg - famsikloviiri
axilur vet 250 mg tabletti
intervet international b.v. - fenbendazole - tabletti - 250 mg - fenbendatsoli
axilur vet 22 % rakeet
intervet international b.v. - fenbendazole - rakeet - 22 % - fenbendatsoli
axilur vet 500 mg tabletti
intervet international b.v. - fenbendazole - tabletti - 500 mg - fenbendatsoli
clopidogrel viatris (previously clopidogrel taw pharma)
viatris limited - klopidogreelibesilata - peripheral vascular diseases; stroke; myocardial infarction - antitromboottiset aineet - secondary prevention of atherothrombotic events clopidogrel is indicated in:adult patients suffering from myocardial infarction (from a few days until less than 35 days), ischemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease. adult patients suffering from acute coronary syndrome. non-st segment elevation acute coronary syndrome (unstable angina or non-q-wave myocardial infarction), including patients undergoing a stent placement following percutaneous coronary intervention, in combination with acetylsalicylic acid (asa). st-segmentin nousua akuutti sydäninfarkti, yhdessä asa lääketieteellisesti hoitoa saaneilla potilailla oikeutettu liuotushoito. in patients with moderate to high-risk transient ischaemic attack (tia) or minor ischaemic stroke (is) clopidogrel in combination with asa is indicated in:adult patients with moderate to high-risk tia (abcd2 score ≥4) or minor is (nihss ≤3) within 24 hours of either the tia or is event. prevention of atherothrombotic and thromboembolic events in atrial fibrillation:in adult patients with atrial fibrillation who have at least one risk factor for vascular events, are not suitable for treatment with vitamin k antagonists (vka) and who have a low bleeding risk, clopidogrel is indicated in combination with asa for the prevention of atherothrombotic and thromboembolic events, including stroke. lisätietoja, katso kohta 5.
metoprolol orion 23.75 mg depottabletti
orion corporation - metoprolol succinate - depottabletti - 23.75 mg - metoprololi
metoprolol orion 47.5 mg depottabletti
orion corporation - metoprolol succinate - depottabletti - 47.5 mg - metoprololi
metoprolol orion 95 mg depottabletti
orion corporation - metoprolol succinate - depottabletti - 95 mg - metoprololi
metoprolol orion 190 mg depottabletti
orion corporation - metoprolol succinate - depottabletti - 190 mg - metoprololi
clopidogrel bgr (previously zylagren)
biogaran - clopidogrel (as hydrogen sulfate) - peripheral vascular diseases; stroke; myocardial infarction - antitromboottiset aineet - aterotromboottisten tapahtumien estämiseen klopidogreeli on tarkoitettu:aikuisille potilaille, jotka kärsivät sydäninfarkti (josta on muutama vuorokausi, mutta enintään 35 vuorokautta), iskeeminen aivohalvaus (josta on 7 vuorokautta, mutta alle 6 kuukautta) tai perifeerinen valtimosairaus.